Postdoctoral Researchers

Dra. Milagros Castellanos

Milagros Castellanos studied Biology at the Universidad Complutense de Madrid. In 2011 she obtained her Ph.D. at the Universidad Autonoma de Madrid under the guidance of Prof. Mauricio García Mateu (CBMSO). She worked in the structural, thermal and mechanical properties of viruses and their impact in the viral function and future nanotechnological applications.

In 2013 she moved to Prof. Víctor Muñoz’s lab (CNB-IMDEA Nanosciece), where participate as a “Juan de la Cierva” posdoc in several projects individually or in collaboration. Her research mainly focused on biophysical characterization of protein-DNA interactions, protein folding and amyloids’ structural-functional relationship. Currently she joined Dr. Álvaro Somoza’s group (IMDEA Nanoscience) as a Postdoctoral researcher participating in several projects which aims the successful application of cutting-edge nanobiotools for the detection and treatment of several diseases such as cancer.



Luis Alberto Campos has been working in biophysical studies related with proteins for the last two decades. In 2003, He obtained his PhD in biochemistry under the supervision of Prof. Javier Sancho at the University of Zaragoza, working on biophysical studies focused on protein folding and stability, and later, he continued his scientific studies with a postdoctoral stay at the University of Maryland in the laboratory directed by Prof. Victor Muñoz, using single molecule techniques to study protein folding. In 2008, he moved to the Centro de Investigaciones Biológicas, in Madrid, where he continued studying protein folding of barrierless proteins, being the recipient of a Marie Curie fellowship. Later on, he moved to the Centro Nacional de Biotecnología, in Madrid, where he obtained a Ramón y Cajal fellowship in 2014. There, he was the principal investigator of a National grant project focused on rational engineering of protein assemblies.

Nowadays, he has joined Dr. Alvaro Somoza´s laboratory in the IMDEA nanoscience institute, where he is going to participate in the improvement of detection and treatment methods using derivatized nanoparticles.



Mario Martínez-Mingo obtained his BSc in Chemistry in 2015 from Universidad Autónoma de Madrid and his MSc in 2016 at the same university under the supervision of Dr. María Ribagorda and Prof. Carmen Carreño.

He then realized his PhD at Universidad Autónoma de Madrid under the supervision of Prof. Juan Carlos Carretero and Dr. Nuria Rodríguez focusing on the selective functionalization of C–H bonds through long-range metallacycle intermediates, stabilized by sulfur containing coordinating moieties. Currently, he joined Dr. Álvaro Somoza´s group as a post-doctoral researcher in IMDEA Nanoscience.



Eduardo García Garrido studied Chemistry at the Universidad Autónoma de Madrid (2011-2015) where he also obtained his master degree in Organic Chemistry (2016) working in the synthesis of different phthalocyanines derivatives and its precursors. From February 2017, he started his PhD at IMDEA Nanociencia, under the supervision of Dr. Álvaro Somoza, where he focused in the synthesis of linkers and biomolecules to control the biological activity of modified nanoparticles.

In 2021, he became PhD in Organic Chemistry and Awesomeness.

Fun facts: He is Leo, a natural born artist, vegetarian/vegan and loves the rainy days.



Hernán Alarcón studied Biology at the Universidad Autónoma de Madrid where he collaborated on the analysis of different biomaterials for the treatment of bone diseases by using mesenchymal stem cells derived from the human bone marrow. After his graduate studies, he got his master’s degree in Biotechnology at the same university and worked as an internship researcher at the Molecular Biology Department. In 2019 he obtained his Ph.D. at the Molecular Biology Department of Universidad Autónoma de Madrid. His work was focused on the development of a lentiviral vector collection to express wild type and two mutant antagonist human prolactin hormones with the potential to describe the effect of human prolactin on various biological processes. Recently, he joined Dr. Begoña Sot’s group (IMDEA Nanoscience) as a Postdoctoral researcher to participate in the development of colorimetric sensors based on gold nanoparticles for the detection of SARS-CoV-2.


Miguel Gisbert Garzarán studied Physics at Universidad de Zaragoza. Then, he got a master’s degree in Biomedical Physics at Universidad Complutense de Madrid. In 2019, he obtained his PhD in Pharmacy from the same university, in the group of Prof. María Vallet-Regí under the supervision of Dr. Miguel Manzano. He also joined the Institute for Integrated Cell-Material Science (Kyoto University, Prof. Fuyuhiko Tamanoi’s lab) for a 3-month predoctoral stay. He carried out his first postdoctoral stay at Universidad Complutense de Madrid, to then join the group of Dr. Julien Nicolas at Institut Galien Paris-Saclay (Paris-Saclay University), under the supervision of Dr. Simona Mura. He is currently a postdoc in the group of Dr. Álvaro Somoza at IMDEA Nanociencia.

Miguel has mainly focused on the use of mesoporous nanoparticles for drug delivery against cancer and infection, although he has also worked on the protein corona of polymeric and lipid prodrug nanoparticles. Currently, he is working on functionalized nanoparticles for Duchenne muscular dystrophy.



During my doctoral thesis I focused on the asymmetric synthesis of β and δ-amino acids, emphasizing the design and preparation of PNA (peptidic-nucleic acid) monomers and analogs of Ezetimibe in a stereocontrolled manner. Using SOD (Diversity Oriented Synthesis) where a key intermediate is transformed into different amino acids following an orthogonal synthesis. Also, use Chemical Computing for drug design and the study of chemical-physical properties (molecular coupling and conformational analysis).
During my postdoctoral stay at the University of Burgos, I synthesized various polyaromatic molecules that have been used as sensors for drugs and explosives by fluorescence and synthesized various selective fluorophores that can be used in the treatment of diabetes.